PITTSBURGH--(BUSINESS WIRE)--Rinovum Women's Health announced today that The Stork ® OTC – the only FDA-cleared over-the-counter device designed to optimize the chances of at-home conception – is now available for purchase in 1,292 Target stores across the United States. The Stork OTC is also available at major pharmacy chains nationwide.
Using the cervical cap insemination technique, The Stork® OTC offers a safe, easy-to-use treatment option for couples trying to build a family naturally in the privacy of their own home.
The Stork OTC is a uniquely designed medical device that uses a condom-like sheath to deliver sperm as closely as possible to the cervical opening. The cervical cap insemination technique has up to a 20% success rate. This innovative alternative can be especially helpful for the 7.3 million people in the U.S. experiencing difficulty conceiving due to infertility1.
“The Stork OTC is a safe option for couples facing challenges with infertility,” said Stephen Bollinger, Rinovum President and CEO. “It’s an easy-to-use, drug-free, cost-effective way to assist your chances to conceive a child.”
This type of treatment has been used effectively in the professional setting, but now it’s readily available to couples at home.
The Stork OTC can be used for common fertility issues in both men and women including:
- Couples with unexplained infertility
- Men with low sperm count or low sperm motility
- Women with unfavorable vaginal environment (pH imbalances)
- Couples trying to become pregnant without having intercourse
The Stork OTC is available for purchase at Target nationwide and online for the average retail price of $79.99, making it more accessible and less expensive than other first-line options for all couples trying to conceive.
To learn more about how The Stork OTC works, watch the full video here. For more information and online availability, as well as pregnancy stories, visit www.storkotc.com. To purchase online at participating retailers, visit www.target.com, www.cvs.com and www.walgreens.com.
About The Stork Ib2C, Inc., A Rinovum Women’s Health Company
Rinovum Women's Health is a privately held women's health company dedicated to bringing products into the market that will enhance women's lives and empower them to take charge of their health. The Stork Ib2C, Inc., A Rinovum Women’s Health Company, launched its flagship product, The Stork® OTC, which is a conception device for reproductive health to assist in natural fertility and conception in the privacy of the patient’s home. Rinovum Women's Health aims to support the development of products that are easy-to-use and safe, as well as a more economical way for a couple to address some of these issues. For more information about Rinovum Women's Health, The Stork Ib2C, Inc., and The Stork OTC, visit www.rinovum.com and www.storkotc.com.
Minneapolis-based Target Corporation (NYSE:TGT) serves guests at 1,806 stores and at Target.com. Since 1946, Target has given 5 percent of its profit to communities, which today equals millions of dollars a week. For more information, visit Target.com/Pressroom. For a behind-the-scenes look at Target, visit Target.com/abullseyeview or follow @TargetNews on Twitter.
1 National Institutes of Health, National Institute of Child Health and Human Development; http://www.nichd.nih.gov/health/topics/infertility/conditioninfo/Pages/common.aspx